| Spacer endoprosthesis for the treatment of infected total hip arthroplasty. | |
| | |
MedLine Citation:
|
PMID: 15343538 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We reviewed the treatment of infected total hip arthroplasty with a temporary spacer endoprosthesis. To fabricate the spacer, antibiotic-loaded cement was inserted into a specially designed mold. A central rod pin was superficially imbedded as an endoskeleton once the cement reached a doughy state. After polymerization, the final product was removed from the mold and inserted as an articulating spacer. Twenty patients were followed for an average of 38 months (range, 26-67 months). There were no recurrent or persistent infections. Eighteen patients underwent a successful 2-stage exchange. Two patients retained the spacer as a definitive treatment method. Complications with the spacer included 2 fractures and 2 dislocations. Overall, this cost-effective technique provided efficient local antibiotic delivery, early mobilization, facilitation of reimplantation, and improved patient satisfaction. |
| | |
Authors:
|
Sridhar M Durbhakula; John Czajka; Marc D Fuchs; Richard L Uhl |
Related Documents
:
|
11326488 - Systemic onset juvenile chronic arthritis, polyarticular pattern and hip involvement as... 8291408 - Indomethacin for prevention of heterotopic ossification. a randomized controlled study ... 10738878 - Total hip arthroplasty after arthrodesis of the hip joint. 15691298 - Inflammatory bowel disease related osteonecrosis: report of a large series with a revie... 23236238 - Trends in the eradication rates of helicobacter pylori infection for eleven years. 12602918 - Simple anesthesia for simple mastectomies. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: The Journal of arthroplasty Volume: 19 ISSN: 0883-5403 ISO Abbreviation: J Arthroplasty Publication Date: 2004 Sep |
Date Detail:
|
Created Date: 2004-09-02 Completed Date: 2004-12-23 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8703515 Medline TA: J Arthroplasty Country: United States |
Other Details:
|
Languages: eng Pagination: 760-7 Citation Subset: IM |
Affiliation:
|
Division of Orthopaedic Surgery, Albany Medical Center, New York, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Aged, 80 and over Anti-Bacterial Agents / administration & dosage* Arthroplasty, Replacement, Hip / instrumentation* Bone Cements* Debridement Female Follow-Up Studies Hip Prosthesis / adverse effects* Humans Male Middle Aged Postoperative Complications Prosthesis Design Prosthesis-Related Infections / surgery* Reoperation Tobramycin / administration & dosage Treatment Outcome Vancomycin / administration & dosage |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Bacterial Agents; 0/Bone Cements; 1404-90-6/Vancomycin; 32986-56-4/Tobramycin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: "Wandering resident" surgical exposure for 1- or 2-stage revision arthroplasty in stiff aseptic and ...
Next Document: Antibiotic-loaded articulating cement spacer in the 2-stage exchange of infected total knee arthropl...